Agomab Therapeutics NV (‘Agomab’) today announced positive interim results from 44 patients completing treatment in the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal ...

The global mortuary equipment market is set to witness steady growth, expanding at a 5.8% CAGR between 2023 and 2033. Valued at USD 1,025.8 million in 2023, the market is projected to reach USD 1,807.